Abstract Details

Title NT-3 Gene Therapy Improves Peripheral Nerve Pathology and Function in Mouse Model for Charcot-Marie-Tooth (CMT) Neuropathy

Topic Neurogenetics and Gene Therapy

Presentation(s) (-)

Poster/Presentation
Number 002

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Zarife Sahenk, MD, PhD, FAAN (The Research Institute at Nationwide Childrens.org)	Dr. Sahenk has nothing to disclose.
Jerry R. Mendell, MD, FAAN (The Research Institute at Nationwide Children's Hospital)	Dr. Mendell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vertex. Dr. Mendell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Mendell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sarepta Therapeutics . The institution of Dr. Mendell has received research support from Sarepta.
Christopher Edwards (The Research Institute At Nationwide Children)	No disclosure on file
	No disclosure on file
Brian K. Kaspar, PhD	No disclosure on file
K. Reed Clark, PhD	No disclosure on file

��ɫ��